169 related articles for article (PubMed ID: 21062390)
1. Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir.
Renaud C; Pergam SA; Polyak C; Jain R; Kuypers J; Englund JA; Corey L; Boeckh MJ
Transpl Infect Dis; 2010 Dec; 12(6):513-7. PubMed ID: 21062390
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H275Y neuraminidase mutation.
Abed Y; Pizzorno A; Boivin G
Antimicrob Agents Chemother; 2012 Aug; 56(8):4375-80. PubMed ID: 22664977
[TBL] [Abstract][Full Text] [Related]
3. Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016.
Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Kuwahara T; Shimazu Y; Shimomura T; Watanabe S; Odagiri T;
Euro Surveill; 2016 Jun; 21(24):. PubMed ID: 27336226
[TBL] [Abstract][Full Text] [Related]
4. Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.
Pizzorno A; Abed Y; Bouhy X; Beaulieu E; Mallett C; Russell R; Boivin G
Antimicrob Agents Chemother; 2012 Mar; 56(3):1208-14. PubMed ID: 22203589
[TBL] [Abstract][Full Text] [Related]
5. Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts.
Memoli MJ; Hrabal RJ; Hassantoufighi A; Eichelberger MC; Taubenberger JK
Clin Infect Dis; 2010 May; 50(9):1252-5. PubMed ID: 20345239
[TBL] [Abstract][Full Text] [Related]
6. A community cluster of influenza A(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013.
Takashita E; Ejima M; Itoh R; Miura M; Ohnishi A; Nishimura H; Odagiri T; Tashiro M
Euro Surveill; 2014 Jan; 19(1):. PubMed ID: 24434172
[TBL] [Abstract][Full Text] [Related]
7. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.
Tamura D; DeBiasi RL; Okomo-Adhiambo M; Mishin VP; Campbell AP; Loechelt B; Wiedermann BL; Fry AM; Gubareva LV
J Infect Dis; 2015 Oct; 212(8):1209-13. PubMed ID: 25943200
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: a case report.
Harada N; Shibata W; Koh H; Takashita E; Fujisaki S; Okamura H; Nanno S; Yamada K; Nakamae H; Hino M; Kakeya H
BMC Infect Dis; 2020 Jul; 20(1):478. PubMed ID: 32631240
[TBL] [Abstract][Full Text] [Related]
9. Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.
Smee DF; Hurst BL; Wong MH; Tarbet EB; Babu YS; Klumpp K; Morrey JD
Antiviral Res; 2010 Oct; 88(1):38-44. PubMed ID: 20633577
[TBL] [Abstract][Full Text] [Related]
10. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
[TBL] [Abstract][Full Text] [Related]
11. Drugs: Lines of defence.
Palmer R
Nature; 2011 Dec; 480(7376):S9-10. PubMed ID: 22158299
[No Abstract] [Full Text] [Related]
12. Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients.
Couturier BA; Bender JM; Schwarz MA; Pavia AT; Hanson KE; She RC
Influenza Other Respir Viruses; 2010 Jul; 4(4):199-204. PubMed ID: 20836794
[TBL] [Abstract][Full Text] [Related]
13. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.
Gubareva LV; Besselaar TG; Daniels RS; Fry A; Gregory V; Huang W; Hurt AC; Jorquera PA; Lackenby A; Leang SK; Lo J; Pereyaslov D; Rebelo-de-Andrade H; Siqueira MM; Takashita E; Odagiri T; Wang D; Zhang W; Meijer A
Antiviral Res; 2017 Oct; 146():12-20. PubMed ID: 28802866
[TBL] [Abstract][Full Text] [Related]
14. [Current anti-influenza virus chemotherapy].
Yoshioka D; Tokimatsu I; Ishii H; Kadota J
Nihon Rinsho; 2010 Sep; 68(9):1679-84. PubMed ID: 20845747
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
Okomo-Adhiambo M; Sleeman K; Lysén C; Nguyen HT; Xu X; Li Y; Klimov AI; Gubareva LV
Influenza Other Respir Viruses; 2013 Sep; 7(5):645-58. PubMed ID: 23575174
[TBL] [Abstract][Full Text] [Related]
16. Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan.
Takashita E; Fujisaki S; Kishida N; Xu H; Imai M; Tashiro M; Odagiri T;
Influenza Other Respir Viruses; 2013 Nov; 7(6):1390-9. PubMed ID: 23745712
[TBL] [Abstract][Full Text] [Related]
17. E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.
L'Huillier AG; Abed Y; Petty TJ; Cordey S; Thomas Y; Bouhy X; Schibler M; Simon A; Chalandon Y; van Delden C; Zdobnov E; Boquete-Suter P; Boivin G; Kaiser L
J Infect Dis; 2015 Dec; 212(11):1726-34. PubMed ID: 25985905
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
[TBL] [Abstract][Full Text] [Related]
19. Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09.
Louie JK; Yang S; Yen C; Acosta M; Schechter R; Uyeki TM
PLoS One; 2012; 7(6):e40261. PubMed ID: 22768265
[TBL] [Abstract][Full Text] [Related]
20. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
Wang B; Dwyer DE; Blyth CC; Soedjono M; Shi H; Kesson A; Ratnamohan M; McPhie K; Cunningham AL; Saksena NK
Antiviral Res; 2010 Jul; 87(1):16-21. PubMed ID: 20385168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
